Palm Beach Research Center

The trials here

What the 15 trials at this site are about, from their registry records.

Conditions

• Obesity7 trials
• Obstructive sleep apnoea6 trials
• Osteoarthritis3 trials
• Type 2 diabetes3 trials
• Alzheimer disease1 trial
• Migraine1 trial

Phase

• Phase 310 trials
• Phase 24 trials
• Phase 2/31 trial

Status

• Completed6 trials
• Active, not recruiting5 trials
• Recruiting3 trials
• Enrolling by invitation1 trial

Lead sponsor

• Eli Lilly and Company4 trials
• Novo Nordisk A/S3 trials
• Incannex Healthcare Ltd2 trials
• Zealand Pharma2 trials
• Apnimed1 trial
• and 3 more

Running trials

• Recruiting

  A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

  NCT07668414· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.

  NCT07635563· Phase 2· Incannex Healthcare Ltd· Source

  Contact: Jennifer Butler

• Recruiting

  AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

  NCT07571109· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Active, not recruiting

  Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide

  NCT07220759· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee

  NCT06884865· Phase 2· Pacira Pharmaceuticals, Inc· Source

  Contact: Lisa Ramsay, MA

• Enrolling by invitation

  Continuation Protocol for Obstructive Sleep Apnea (OSA)

  NCT06566820· Phase 3· Apnimed· Source

• Active, not recruiting

  RCT, Blinded, 2-Arm Efficacy Study of IP and Placebo in Patients With Chronic Pain Related to Osteoarthritis of the Knee

  NCT05318521· Phase 3· Overseas Pharmaceuticals, Ltd.· Source

• Active, not recruiting

  A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

  NCT05026866· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine

  NCT04616326· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obstructive sleep apnoea3 recruiting
• Obesity2 recruiting

Closed trials

• Completed

  Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

  NCT06926842· Phase 2· Zealand Pharma· Source

• Completed

  Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities

  NCT06662539· Phase 2· Zealand Pharma· Source

• Completed

  RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA

  NCT06146101· Phase 2/3· Incannex Healthcare Ltd· Source

• Completed

  A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight

  NCT05929079· Phase 3· Eli Lilly and Company· Source

• Completed

  Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 Injections for Pain Associated With Osteoarthritis of the Knee

  NCT05377489· Phase 3· Grünenthal GmbH· Source

• Completed

  Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea

  NCT05412004· Phase 3· Eli Lilly and Company· Source